Prognostic value of small mother against decapentaplegic expression in human gastric cancer

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–386.
   PubMed Web of Science ®Google Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700–713.
   PubMed Web of Science ®Google Scholar
• Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:531–546.
   PubMed Web of Science ®Google Scholar
• Nashimoto A, Nakajima T, Furukawa H, et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan clinical oncology group 9206-1. J Clin Oncol. 2003;21:2282–2287.
   PubMed Web of Science ®Google Scholar
• De Vita F, Giuliani F, Galizia G, et al. Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol. 2007;18(Suppl 6):vi120–123.
   PubMedGoogle Scholar
• Hamashima C. Current issues and future perspectives of gastric cancer screening. World J Gastroenterol. 2014;20:13767–13774.
   PubMed Web of Science ®Google Scholar
• Singh P, Wig JD, Srinivasan R. The Smad family and its role in pancreatic cancer. Indian J Cancer. 2011;48:351–360.
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–584.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11:91–102.
   PubMed Web of Science ®Google Scholar
• Li YP, Du XR, Zhang R, et al. Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-β1 axis. Bioengineered. 2021;12:763–778.
   PubMed Web of Science ®Google Scholar
• Chihara Y, Shimoda M, Hori A, et al. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells. Breast Cancer Res Treat. 2017;166:55–68.
   PubMed Web of Science ®Google Scholar
• Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006;69:597–607.
   PubMed Web of Science ®Google Scholar
• Zheng T, Qiu J, Li C, et al. Long noncoding RNA LINC00673 promotes the proliferation and metastasis of epithelial ovarian cancer by associating with opioid growth factor receptor. Onco Targets Ther. 2019;12:6145–6156.
   PubMed Web of Science ®Google Scholar
• Lima A, Oliveira J, Saúde F, et al. Proteins in soy might have a higher role in cancer prevention than previously expected: soybean protein fractions are more effective MMP-9 inhibitors than non-protein fractions, even in cooked seeds. Nutrients. 2017;9:9.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhu H, Weng M, et al. Baohuoside-1 targeting mTOR inducing apoptosis to inhibit hepatocellular carcinoma proliferation, invasion and migration. Biomed Pharmacother. 2020;128:110366.
   PubMed Web of Science ®Google Scholar
• Ni F, Tang H, Wang C, et al. Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system. Cancer Manag Res. 2019;11:8391–8405.
   PubMed Web of Science ®Google Scholar
• Qu F, Zheng J, Gan W, et al. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1. Oncotarget. 2017;8:52465–52473.
   PubMedGoogle Scholar
• Gomez-Puerto MC, Iyengar PV, García de Vinuesa A. Bone morphogenetic protein receptor signal transduction in human disease. J Pathol. 2019;247:9–20.
   PubMed Web of Science ®Google Scholar
• Moussa MM, Helal NS, Youssef MM. Significance of pSmad2/3 and Smad4 in hepatitis C virus-related liver fibrosis and hepatocellular carcinoma. Apmis. 2018;126:477–485.
   PubMed Web of Science ®Google Scholar
• Goumans MJ, Mummery C. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol. 2000;44:253–265.
   PubMed Web of Science ®Google Scholar
• Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol. 2006;26:654–667.
   PubMed Web of Science ®Google Scholar
• Uemura M, Swenson ES, Gaça MD, et al. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Biol Cell. 2005;16:4214–4224.
   PubMed Web of Science ®Google Scholar
• Liang B, Che J, Zhao H, et al. MiR-195 promotes abdominal aortic aneurysm media remodeling by targeting Smad3. Cardiovasc Ther. 2017;35:35.
   Web of Science ®Google Scholar
• Hackinger S, Trajanoska K, Styrkarsdottir U, et al. Evaluation of shared genetic aetiology between osteoarthritis and bone mineral density identifies SMAD3 as a novel osteoarthritis risk locus. Hum Mol Genet. 2017;26:3850–3858.
   PubMed Web of Science ®Google Scholar
• Wang T, Liu Y, Zou JF, et al. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation. PLoS One. 2017;12:e0183972.
   PubMed Web of Science ®Google Scholar
• Khalil H, Kanisicak O, Prasad V, et al. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. J Clin Invest. 2017;127:3770–3783.
   PubMed Web of Science ®Google Scholar
• Zhu C, Huang Q, Zhu H. Melatonin inhibits the proliferation of gastric cancer cells through regulating the miR-16-5p-Smad3 pathway. DNA Cell Biol. 2018;37:244–252.
   PubMed Web of Science ®Google Scholar
• Kundu J, Wahab SM, Kundu JK, et al. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling. Int J Oncol. 2012;41:839–848.
   PubMed Web of Science ®Google Scholar
• Fang Y, Liu Z, Chen Z, et al. Smad5 acts as an intracellular pH messenger and maintains bioenergetic homeostasis. Cell Res. 2017;27:1083–1099.
   PubMed Web of Science ®Google Scholar
• Yan X, Liao H, Cheng M, et al. Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J Biol Chem. 2016;291:382–392.
   PubMed Web of Science ®Google Scholar
• Yu Y, Gu S, Li W, et al. Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling. Proc Natl Acad Sci U S A. 2017;114:10113–10118.
   PubMed Web of Science ®Google Scholar
• Xu J, Li J, Wang H, et al. A novel SMAD family protein, SMAD9 is involved in follicular initiation and changes egg yield of geese via synonymous mutations in exon1 and intron2. Mol Biol Rep. 2015;42:289–302.
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Mizuta T, Fujimoto M, et al. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Sci Rep. 2014;4:7596.
   PubMed Web of Science ®Google Scholar
• Ngeow J, Yu W, Yehia L, et al. Exome sequencing reveals germline SMAD9 mutation that reduces phosphatase and tensin homolog expression and is associated with hamartomatous polyposis and gastrointestinal ganglioneuromas. Gastroenterology. 2015;149(886–889):e885.
   Google Scholar
• Ojima H, Araki K, Kato T, et al. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer. Anticancer Res. 2006;26(2B):1385–1390.
   Google Scholar
• Sabesan A, Petrelli NJ, Bennett JJ. Outcomes of gastric cancer resections performed in a high volume community cancer center. Surg Oncol. 2015;24:16–20.
   PubMed Web of Science ®Google Scholar
• Roder JD, Böttcher K, Busch R, et al. Classification of regional lymph node metastasis from gastric carcinoma. German gastric cancer study group. Cancer. 1998;82:621–631.
   PubMed Web of Science ®Google Scholar
• Harada K, Mizrak Kaya D, Shimodaira Y, et al. Global chemotherapy development for gastric cancer. Gastric Cancer. 2017;20:92–101.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wan H, Lin Y, et al. Androgen receptor may be responsible for gender disparity in gastric cancer. Med Hypotheses. 2013;80:672–674.
   PubMed Web of Science ®Google Scholar
• Dickson JL, Cunningham D. Systemic treatment of gastric cancer. Eur J Gastroenterol Hepatol. 2004;16:255–263.
   PubMed Web of Science ®Google Scholar
• Yu B, Gu D, Zhang X, et al. The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer. J Genet Genomics. 2017;44:375–383.
   PubMed Web of Science ®Google Scholar
• Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: an update. World J Gastroenterol. 2016;22:4619–4625.
   PubMed Web of Science ®Google Scholar
• Alberts DS, Marth C, Alvarez RD, et al. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival. Gynecol Oncol. 2008;109:174–181.
   PubMed Web of Science ®Google Scholar